{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T05:14:56Z","timestamp":1790054096920,"version":"4.0.1"},"reference-count":11,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Genetics and Cytogenetics"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1016\/j.cancergencyto.2005.08.006","type":"journal-article","created":{"date-parts":[[2006,1,27]],"date-time":"2006-01-27T14:54:49Z","timestamp":1138373689000},"page":"164-167","source":"Crossref","is-referenced-by-count":9,"title":["Genotoxicity of etoposide: greater susceptibility of MLL than other target genes"],"prefix":"10.1016","volume":"164","author":[{"given":"A.","family":"Ng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.M.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.B.","family":"Eden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergencyto.2005.08.006_bib1","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1182\/blood.V87.7.2649.bloodjournal8772649","article-title":"Site-specific DNA cleavage within the MLL breakpoint cluster region induced by topo 2 inhibitors","volume":"87","author":"Aplan","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2005.08.006_bib2","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1093\/hmg\/9.11.1671","article-title":"DNA structural properties of AF9 are similar to MLL and could act as recombination hot spots resulting in MLL\/AF9 translocations and leukemogenesis","volume":"9","author":"Strissel","year":"2000","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.cancergencyto.2005.08.006_bib3","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/sj.leu.2400632","article-title":"Topoisomerase 2 inhibitors induce DNA double-strand breaks at a specific site within the AML1 locus","volume":"11","author":"Stanulla","year":"1997","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2005.08.006_bib4","doi-asserted-by":"crossref","first-page":"8448","DOI":"10.1038\/sj.onc.1207052","article-title":"Reciprocal DNA topoisomerase 2 cleavage events at 5'-TATTA-3' sequences in MLL and AF9 create homologous single-stranded overhangs that anneal to form der(11) and der(9) genomic breakpoint junctions in treatment-related AML without further processing","volume":"22","author":"Whitmarsh","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.cancergencyto.2005.08.006_bib5","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1093\/nar\/23.14.2762","article-title":"Alternative splicing and genomic structure of the AML1 gene involved in acute myeloid leukemia","volume":"23","author":"Miyoshi","year":"1995","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.cancergencyto.2005.08.006_bib6","first-page":"4881","article-title":"Etoposide pharmacokinetics in children: the development & prospective validation of a dosing equation","volume":"53","author":"Lowis","year":"1993","journal-title":"Cancer Res"},{"key":"10.1016\/j.cancergencyto.2005.08.006_bib7","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1096\/fj.03-0638fje","article-title":"Etoposide induces chimeric Mll gene fusions","volume":"18","author":"Blanco","year":"2004","journal-title":"FASEB J"},{"key":"10.1016\/j.cancergencyto.2005.08.006_bib8","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/(SICI)1098-2264(200006)28:2<227::AID-GCC12>3.0.CO;2-J","article-title":"Concurrent translocations of MLL and CBFA2 (AML1) genes with new partner breakpoints in a child with secondary myelodysplastic syndrome after treatment of acute lymphoblastic leukemia","volume":"28","author":"Mathew","year":"2000","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergencyto.2005.08.006_bib9","first-page":"4287","article-title":"Chromosome band 11q23 translocation breakpoints are DNA topoisomerase 2 cleavage sites","volume":"55","author":"Felix","year":"1995","journal-title":"Cancer Res"},{"key":"10.1016\/j.cancergencyto.2005.08.006_bib10","doi-asserted-by":"crossref","first-page":"9802","DOI":"10.1073\/pnas.171309898","article-title":"Near-precise interchromosomal recombination and functional DNA topoisomerase 2 cleavage sites at MLL and AF-4 genomic breakpoints in treatment-related acute lymphoblastic leukemia with t(4;11) translocation","volume":"98","author":"Lovett","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cancergencyto.2005.08.006_bib11","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1021\/bi002361x","article-title":"Etoposide metabolites enhance DNA topoisomerase 2 cleavage near leukemia-associated MLL translocation breakpoints","volume":"40","author":"Lovett","year":"2001","journal-title":"Biochemistry"}],"container-title":["Cancer Genetics and Cytogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460805004590?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460805004590?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,12]],"date-time":"2020-04-12T10:45:49Z","timestamp":1586688349000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165460805004590"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":11,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["S0165460805004590"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergencyto.2005.08.006","relation":{},"ISSN":["0165-4608"],"issn-type":[{"value":"0165-4608","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1]]}}}